Seres Therapeutics (MCRB) Prepaid Assets (2014 - 2026)

Seres Therapeutics has reported Prepaid Assets for 13 years, with the latest figure at $1.8 million in Q1 2026.

• Quarterly Prepaid Assets fell 60.38% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (down 60.38% YoY) and the FY2025 annual result came in at $3.1 million, down 46.79% from the prior year.
• Prepaid Assets fell to $1.8 million in Q1 2026 per MCRB's latest filing, from $3.1 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $15.2 million in Q1 2022 and troughed at $1.8 million in Q1 2026.
• A 5-year average of $7.7 million and a median of $6.4 million in 2024 frame the typical range for Prepaid Assets.
• The sharpest annual moves came in 2022 and 2025: Prepaid Assets soared 131.96% in 2022, then slumped 62.33% in 2025.
• Over 5 years, Prepaid Assets stood at $13.4 million in 2022, then slumped by 40.04% to $8.0 million in 2023, then declined by 27.78% to $5.8 million in 2024, then tumbled by 46.79% to $3.1 million in 2025, then slumped by 42.77% to $1.8 million in 2026.
• According to Business Quant data, Prepaid Assets over the past three periods registered $1.8 million, $3.1 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.